Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Soft Tissue Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Medical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hanzhong, Zhejiang, China
Contact: Study coordinator (Ying Dong) · dongying74@zju.edu.cn · （0571）87783730

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Advanced Dedifferentiated Liposarcoma · Advanced Leiomyosarcoma · Advanced Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma · Sarcoma,Soft Tissue · Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Breast Cancer, NOS · CNS Primary Tumor, NOS · Cervical Cancer, NOS

Abroad (travel likely)Recruiting

Fairbanks, United States · Kingman, United States

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States